[Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Prophylaxie des infections post-allogreffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 14 05 2018
revised: 19 07 2018
accepted: 27 08 2018
pubmed: 9 1 2019
medline: 15 2 2019
entrez: 9 1 2019
Statut: ppublish

Résumé

Allogeneic hematopoietic stem cell transplantation is a curative treatment for many hematological diseases. However, this procedure causes the patient to be susceptible to infection. Prophylactic treatments are administered in clinical practice even thought the level of evidence of their effectiveness is not always high. In addition, changes in the transplantation procedures - use of reduced intensity conditioning, development of alternative graft sources - must lead to a rethinking of attitudes towards prophylaxis. Our working group based its recommendations on a review of referential articles and publications on the subject found in the literature. These recommendations concern the prophylaxis of infections caused by HSV1, HSV2, varicella zoster, and hepatitis B, as well as anti-bacterial and digestive decontamination prophylaxis, prevention of pneumocystis, toxoplasmosis, tuberculosis, as well as prophylaxis of fungal infections. Other infectious agents usually involved in infections post-allotransplant have been the subject of another set of recommendations from the French Society of Bone Marrow Transplantation and Cellular Therapy.

Identifiants

pubmed: 30616839
pii: S0007-4551(18)30305-9
doi: 10.1016/j.bulcan.2018.08.017
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antiviral Agents 0

Types de publication

Consensus Development Conference Journal Article Practice Guideline Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

S23-S34

Informations de copyright

Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Philippe Lewalle (P)

Institut Jules-Bordet, université Libre-de-Bruxelles, service d'hématologie, 1, rue Héger-Bordet, 1000 Bruxelles, Belgique.

Cécile Pochon (C)

CHU de Nancy, service d'onco-hématologie pédiatrique, rue du Morvan, 54511 Vandoeuvre-lès-Nancy, France.

Mauricette Michallet (M)

Centre Léon-Bérard, service d'hématologie, 69008 Lyon, France.

Pascal Turlure (P)

Centre hospitalier universitaire, service d'hématologie, 87042 Limoges, France.

Eolia Brissot (E)

Assistance publique des hôpitaux de Paris (AP-HP), hôpital Saint-Antoine, département d'hématologie, 75012 Paris, France.

Catherine Paillard (C)

Hôpital de Haute-pierre, 67200 Strasbourg, France.

Mathieu Puyade (M)

CHU de Poitiers, service de médecine interne, unité d'hospitalisation d'aval, 2, rue de la Milétrie, 86021 Poitiers cedex, France.

Gabrielle Roth-Guepin (G)

CHU de Brabois, service d'hématologie, Nancy, France.

Ibrahim Yakoub-Agha (I)

CHRU de Lille, service des maladies du sang, 2, avenue Oscar-Lambret, 59037 Lille cedex, France; Université de Lille 2, LIRIC, Inserm U995, 59000 Lille, France.

Sylvain Chantepie (S)

Institut d'hématologie de Basse-Normandie, centre hospitalier universitaire, avenue de la Côte-de-Nacre, 14000 Caen, France. Electronic address: chantepie-s@chu-caen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH